The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -37.64% this year. Over the last six months, there has been a stronger performance of -67.35%. The price of BCYC leaped by -3.85% during the last 30 days period. For the last 5-days stocks have improved 23.48%.
Bicycle Therapeutics Plc ADR’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $28.67 on 10/16/24, and the lowest price during the same period was recorded at $6.10 on 04/09/25.
52-week price history of BCYC Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Bicycle Therapeutics Plc ADR’s current trading price is -69.55% away from its 52-week high, while its distance from the 52-week low is 43.11%. The stock’s price range for this period has been between $6.10 and $28.67. The Healthcare sector company’s shares saw a trading volume of about 0.81 million for the day, which was higher than the average daily volume of 0.34 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Bicycle Therapeutics Plc ADR (BCYC) has experienced a quarterly decline of -35.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 602.89M and boasts a workforce of 305 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.55, with a change in price of -11.81. Similarly, Bicycle Therapeutics Plc ADR recorded 460,966 in trading volume during the last 100 days, posting a change of -57.50%.
BCYC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for BCYC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
BCYC Stock Stochastic Average
As of today, the raw stochastic average of Bicycle Therapeutics Plc ADR over the last 50 days is at 37.52%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 73.26%. Further, the company’s Stochastic %K and %D values for the last 20 days were 49.49% and 40.94%, respectively.
